Latest News

• share
• favorite_border

• share
• favorite_border

Vaccination against COVID-19 did not affect fertility outcomes in patients undergoing in-vitro fertilization (IVF).

• share
• favorite_border

Researchers from the Icahn School of Medicine at Mount Sinai have found that greater increases, decreases, or variability in body mass index (BMI) over time are associated with an accelerated rate of cognitive decline, irrespective of whether a person has normal, overweight or obese body mass index at baseline.

• share
• favorite_border

Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial, Mount Sinai researchers reported in The Lancet Gastroenterology & Hepatology in January.

• share
• favorite_border

The Cathedral of St. John the Divine closes out the year with celebration and song online with the annual New Year’s Eve Concert for Peace, part of the 2021-2022 season of Great Music in a Great Space.

• share
• favorite_border

This year the medical and research advancements from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System ranged from COVID-19, to PTSD, to the first ever successful trachea transplant surgery. Our doctors and researchers were not only at the forefront of the pandemic providing expertise and new studies surrounding the virus, its symptoms and effects, but also excelling in revolutionary surgeries and progressive research to continue showcasing Mount Sinai as a top medical institution and medical school in the country. Here are some of Mount Sinai’s breakthrough stories of the year:

• share
• favorite_border

Generalized pustular psoriasis (GPP) is a rare, life-threatening skin condition for which there are no approved treatments. It is characterized by episodes of widespread eruptions of painful, sterile pustules (blisters of non-infectious pus). There is a high unmet need for treatments that can rapidly and completely resolve the signs and symptoms of GPP flares. Flares greatly affect a person’s quality of life and can lead to hospitalization with serious complications, including heart failure, renal failure, sepsis, and death.

• share
• favorite_border

Mount Sinai Health System is proud to announce that Kenneth L. Davis, MD, its Chief Executive Officer, was recognized by Modern Healthcare as one of the “100 Most Influential People in Healthcare” for 2021.

• share
• favorite_border

A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung cancer than in the past, supporting the need for increased use of screening to save lives, according to a Mount Sinai study published in JAMA Network Open in December.

• share
• favorite_border

Mount Sinai’s Center for Stress, Resilience and Personal Growth (CSRPG) has expanded its resilience training program to people in its surrounding communities through a partnership with faith-based organizations in Harlem, the Bronx, Brooklyn, and Queens, all disproportionately affected by COVID-19

• share
• favorite_border

The Phillips School of Nursing at Mount Sinai Beth Israel (PSON) was granted re-accreditation of its baccalaureate degree program by the Commission on Collegiate Nursing Education (CCNE), a prestigious national accreditation agency that contributes to the improvement of the public's health by ensuring the quality and integrity of baccalaureate and other degree programs in nursing.

• share
• favorite_border

One of the top researchers worldwide studying itch and inflammatory skin conditions, Brian S. Kim, MD, MTR, FAAD, will join Mount Sinai Health System as Director of the newly established Mark Lebwohl Center for Neuroinflammation and Sensation.

• share
• favorite_border

Mount Sinai researchers have solved a major mystery in cancer research: How cancer cells remain dormant for years after they leave a tumor and travel to other parts of the body, before awakening to create metastatic cancer.

• share
• favorite_border

Mount Sinai physician-scientists have found that a novel therapy for the bone marrow cancer myelofibrosis is safe and well-tolerated and is associated with modest improvements in patients in a Phase 1b clinical trial. They shared their findings during an oral presentation at the American Society of Hematology annual meeting in December.

• share
• favorite_border

Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma. Their findings were published as a case study in Nature Medicine in December.

• share
• favorite_border

New York City’s former Chief Medical Examiner, Barbara Sampson, MD, PhD, has joined the Icahn School of Medicine at Mount Sinai as Vice Chair for Laboratory Strategic Initiatives and Academic Affairs, and Professor of Pathology, Molecular, and Cell-Based Medicine.

• share
• favorite_border

New study suggests persistent exposure to air pollutants in residential communities can impact health outcomes for COVID-19 patients

• share
• favorite_border

Mount Sinai researchers have delineated four new subgroups of COVID-19 that can be identified in patients within 24 hours of admission to the intensive care unit (ICU). The finding will help match patients to specific treatments, improving their overall care and outcomes.

• share
• favorite_border

The National Cancer Institute has awarded Mount Sinai researchers $3.15 million in grant funding to assess the potential of a multidisciplinary drug development platform to identify new biological targets for precision-based therapeutics for hepatocellular carcinoma (HCC). The platform includes precision mouse models, tumor 3D organoids, and a proprietary library of small molecule inhibitors.

• share
• favorite_border

An international consortium of scientists dissects the shared genetic architecture of suicide attempts, psychiatric disorders, and non-psychiatric risk factors

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai will serve as a hub site for two cohort studies contributing to a nationwide health consortium study by the National Institutes of Health (NIH) on the long-term effects of SARS-CoV-2, the virus that causes COVID-19.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai is among the 22 recipient institutions of the largest U.S. collaborative funding effort for equity in biomedicine, a $12.1 million effort made possible by the Doris Duke Charitable Foundation.

• share
• favorite_border

• share
• favorite_border

Both rare and commonly observed differences in the DNA letters strung along a person’s chromosomes can explain about a third of the risk for being diagnosed with obsessive-compulsive disorder (OCD), according to a new study led by scientists at the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

• share
• favorite_border

Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potential targeted treatments based on the findings, as reported in Science Advances in November.

• share
• favorite_border

Women who use cannabis during pregnancy, potentially to relieve stress and anxiety, may inadvertently predispose their children to stress susceptibility and anxiety, according to a study conducted by researchers from the Icahn School of Medicine at Mount Sinai and the City University of New York published Monday, November 15, in the Proceedings of the National Academy of Science (PNAS).

• share
• favorite_border

A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.

• share
• favorite_border

• share
• favorite_border

Study outlines better way to identify where stents are necessary

• share
• favorite_border

Joanne L. Stone, MD, a leading physician-scientist in women’s health with special expertise in fetal imaging and caring for high-risk pregnancies, has been named the Chair of Obstetrics, Gynecology, and Reproductive Science for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. Dr. Stone currently serves as Director of the Maternal-Fetal Medicine and Fellowship Program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and immediate past President of the Faculty Council.

• share
• favorite_border

Deep brain stimulation (DBS) has been demonstrated to be an effective treatment for many patients suffering with treatment-resistant depression, but exactly how it works is not known.

• share
• favorite_border

The 32BJ Health Fund and the Mount Sinai Health System today announced expansion of their unique Centers of Excellence program, which provides bariatric and joint replacement surgeries at no-cost to Fund participants, to include partner hospitals in New Jersey, Connecticut, Florida, Massachusetts, and Pennsylvania.

• share
• favorite_border

Fast Company announced today its first annual Brands That Matter list, honoring brands that have achieved relevance through cultural impact and social engagement, and authentically communicated their missions and ideals.

• share
• favorite_border

Mount Sinai study will inform international strategies to support patients experiencing long-term disability due to condition

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai will enroll 11 partner medical schools in its Anti-Racist Transformation (ART) in Medical Education initiative, which seeks to use a formal change management process developed at Mount Sinai to address deeply entrenched racism and bias. The initiative has received generous support from the Josiah Macy Jr. Foundation.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai is establishing a Skin Biology and Diseases Resource-based Center (SBDRC), funded by a $4 million grant from the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

• share
• favorite_border

A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.

• share
• favorite_border

Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in Cancer Cell in October.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai has been awarded a five-year, $16 million grant from the National Institutes of Health (NIH) to foster inclusive excellence in the biomedical sciences using evidence-based approaches.